jeudi 11 mai 2017 – Anne Joly
Bertin Technologies subsidiary gives its activities pharma services and biotech respectively to Amatsigroup, supported by Ekkio Capital, and Oncodesign.
Ekkio Capital supports the Thoiry teams,
affected by this cruel act.
Paris, le 23 février 2017 –Sterience, the French leader in sterilization (in-situ and ex-situ) of medical devices for the surgical environment, announces the arrival of Pierre Forest as President.
Recognized professional in health care, Pierre Forest will replace Jacques Penicaud, who has been the head of the group since its acquisition by Ekkio Capital in 2015. After a first phase of restructuring, the company now focuses its strategy on commercial development and geographical expansion.
A graduate of an HEC MBA and the French Institute of Business and Management, Pierre Forest has more than 30 years experience in sales, marketing and general management of industrial and technological companies in the health sector. He began his career in medical imaging groups before taking up the position of Chief Executive Officer of the Acuson Corporation between 1994 and 2001. He then joined Siemens Medical as Head of the Ultrasound Division for Western Europe.
At the beginning of 2005 his career was in life sciences and in vitro diagnostics. He was appointed Managing Director of Applera France SA and then Abbott France Diagnostics in 2007. These various positions enabled him to acquire a wealth of experience in the direct environment of the care path in medical biology and in the management of teams with diversified profiles. Between 2011 and 2015, Pierre Forest was President of Novescia SAS, France’s leading medical biology network combining clinical and routine. Pierre and his teams successfully completed one of the first consolidations of liberal biology activities in a structured healthcare company. This project was completed by a sale to the Cerba Health Care Group (PAI Partners).
About Sterience: Created in 2001, Sterience is the French leader in sterilization (in-situ and ex-situ) of surgical instruments that can be reused in operating theaters. Thanks to its 260 employees, the group processes more than 700,000 medical devices per year in its 8 sterilization centers in France. Sterience has recently initiated the construction of a new central sterilization site in Reims in partnership with the Courlancy Santé group, an emblematic project of the group’s ability to manage the management of complex and large projects. Ekkio Capital acquired the entire capital in January 2015.
Contact médias : Citigate Dewe Rogerson
Daiana HIRTE 01 53 32 78 90 / 07 60 90 89 12 firstname.lastname@example.org
Paris CityVision acquires Localers.com and extends its offer with 150 new products.
400 references of excursions and activities in Paris and all over France.